Cohance Lifesciences Ltd. demonstrates strong profitability with a substantial ROE, but its high PE ratio indicates it may be overvalued compared to peers. However, it has the lowest debt levels, making it a safer investment compared to others with higher debt ratios. Among its peers, Dr. Reddy's Laboratories stands out for its strong profitability and low valuation metrics, making it a potential value pick.

• • Cohance Lifesciences has the lowest debt to equity ratio (0.0465), indicating low financial risk.
• • Dr. Reddy's Laboratories offers strong profitability with a PE ratio of 15.50, making it a highly attractive value pick.
• • Mankind Pharma shows the highest revenue growth YoY (18.12%) and 3-Year (155.25%), indicating excellent growth potential.